drugset / Trial / NCT06188546

Propofol for Prophylaxis of Morphine Induced Pruritis in Caesarean Section

NCT06188546

Phase 3 Unknown 200 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

the goal of this randomized clinical trial is to find the optimum sub hypnotic dose of iv propofol that prevents the incidence of itching induced from intrathecal morphine used in spinal anesthesia in caesarean section operation. the main questions it aim to answer are the number of patients complained of pruritus in the first 24 hours post operative period and the severity of the pruritus. participants will be divided into 4 groups. 1st group receives 0 mg of propofol , 2nd receives 10 mg , 3rd receives 20 mg and the 4th receives 30 mg.

Timeline

Start
2024-01-01
Primary completion
2025-01-01
Completion
2025-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 10 mg Intravenous
Comparator Propofol Small molecule 20 mg Intravenous
Comparator Propofol Small molecule 30 mg Intravenous

Indications

No indication recorded.